1. Home
  2. DBVT vs RITR Comparison

DBVT vs RITR Comparison

Compare DBVT & RITR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DBVT
  • RITR
  • Stock Information
  • Founded
  • DBVT 2002
  • RITR 2015
  • Country
  • DBVT France
  • RITR Hong Kong
  • Employees
  • DBVT N/A
  • RITR N/A
  • Industry
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • RITR
  • Sector
  • DBVT Health Care
  • RITR
  • Exchange
  • DBVT Nasdaq
  • RITR NYSE
  • Market Cap
  • DBVT 237.4M
  • RITR 221.1M
  • IPO Year
  • DBVT N/A
  • RITR 2024
  • Fundamental
  • Price
  • DBVT $9.40
  • RITR $5.24
  • Analyst Decision
  • DBVT Buy
  • RITR
  • Analyst Count
  • DBVT 4
  • RITR 0
  • Target Price
  • DBVT $14.81
  • RITR N/A
  • AVG Volume (30 Days)
  • DBVT 41.9K
  • RITR 713.4K
  • Earning Date
  • DBVT 07-29-2025
  • RITR 02-15-2025
  • Dividend Yield
  • DBVT N/A
  • RITR N/A
  • EPS Growth
  • DBVT N/A
  • RITR N/A
  • EPS
  • DBVT N/A
  • RITR 0.09
  • Revenue
  • DBVT $3,497,000.00
  • RITR $47,948,887.00
  • Revenue This Year
  • DBVT $1,700.53
  • RITR N/A
  • Revenue Next Year
  • DBVT $535.67
  • RITR N/A
  • P/E Ratio
  • DBVT N/A
  • RITR $60.73
  • Revenue Growth
  • DBVT N/A
  • RITR 278.44
  • 52 Week Low
  • DBVT $2.21
  • RITR $2.24
  • 52 Week High
  • DBVT $12.78
  • RITR $8.75
  • Technical
  • Relative Strength Index (RSI)
  • DBVT 52.73
  • RITR N/A
  • Support Level
  • DBVT $9.00
  • RITR N/A
  • Resistance Level
  • DBVT $10.12
  • RITR N/A
  • Average True Range (ATR)
  • DBVT 0.57
  • RITR 0.00
  • MACD
  • DBVT 0.08
  • RITR 0.00
  • Stochastic Oscillator
  • DBVT 72.24
  • RITR 0.00

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

About RITR REITAR LOGTECH HLDGS LTD

Reitar Logtech Holdings Ltd provide one-stop solutions for logistics property operations in property development and redevelopment projects. It consists of two segments: construction management and engineering design services; and asset management and professional consultancy services in Hong Kong. Key revenue is generated from construction management and engineering design services.

Share on Social Networks: